Microbicide data show promise.
D000180:Acrylic Resins / Q000008:administration & dosage / Q000009:adverse effects; D000282:Administration, Intravaginal; D000349:Africa; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects; D002986:Clinical Trials as Topic; D005260:Female; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission / Q000821:virology; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D008297:Male; D009282:Naphthalenesulfonates / Q000008:administration & dosage / Q000009:adverse effects; D015143:Philadelphia; D011108:Polymers / Q000008:administration & dosage / Q000009:adverse effects; D015229:Sexually Transmitted Diseases, Viral / Q000517:prevention & control* / Q000635:transmission / Q000821:virology; D016896:Treatment Outcome
D000180:Acrylic Resins; D019380:Anti-HIV Agents; C420918:BufferGel; D009282:Naphthalenesulfonates; C120231:PRO 2000; D011108:Polymers